GCT1184-015 A Phase 2, Open-label, Multicohort Study of Rinatabart Sesutecan (Rina-S) in Participants With Non-Small Cell Lung Cancer
- Phase II
- Trial Category: Lung
Contact(s)
Mary Beth Wilwerding, RN Admin@NEcancertrials.com
Location(s)
Available at Nebraska Hematology and Oncology, Lincoln, NE location
Interested in More Information?
Please fill out the form below. Someone will get back to you as soon as possible.
"*" indicates required fields